Dadparvar S, Hussain R, Koffler S P, Gillan M M, Bartolic E I, Miyamoto C
Department of Radiologic Sciences, Hahnemann University Hospital, Philadelphia, Pennsylvania 19102, USA.
Cancer J. 2000 Nov-Dec;6(6):381-7.
Cerebral radionecrosis is a possible complication of brain radiation therapy in patients with primary or metastatic tumors. This retrospective study evaluated the role of Tc-99m hexamethyl propyleneamine oxime (HMPAO) scintigraphy in monitoring the effects of radiation on the brain.
Ninety-eight patients (41 female, 57 male) with a mean age of 51 years (range, 16-82 years) underwent 128 sets of single-photon emission computed tomography studies. TI-201 and Tc-99m HMPAO single-photon emission computed tomography studies were performed for tumor localization and evaluation of the effect of radiation on the cerebral cortex. Thirty concomitant neuropsychological tests and 96 anatomic imaging (computed tomography/magnetic resonance imaging) were performed. The average radiation dose was 52 Gy delivered as 1.8 to 2 Gy/fraction. Thirty-two patients received an average dose of 160 mCi of I-125 EGFr concomitantly. The average follow-up period was 34 months. Abnormalities away from the tumor site were interpreted as positive on HMPAO studies, neuropsychological testing, or anatomic imaging; otherwise, they were classified as negative.
There were 10/45 (22%) and 75/83 (90%) abnormal HMPAO study results before and after radiation therapy. The HMPAO studies compared with neuropsychological testing showed 3/13 (23%) and 14/17 (82%) concordant abnormalities in addition to tumor site in patients pre- versus postradiation therapy. There was better concordance of HMPAO and anatomic imaging in 22/30 (76%) patients versus 24/67 (36%) patients before radiation therapy. HMPAO imaging after radiation therapy revealed significantly more perfusion abnormalities. There were significant differences between all of the aforementioned parameters. CONCLUSION Tc-99m HMPAO imaging is useful in the evaluation of the effects of radiation therapy on the brain and is highly concordant with neuropsychological testing. It is superior to anatomic studies in identifying radiation-induced changes.
脑放射性坏死是原发性或转移性肿瘤患者脑放射治疗可能出现的并发症。本回顾性研究评估了锝-99m六甲基丙烯胺肟(HMPAO)闪烁显像在监测脑部放射治疗效果中的作用。
98例患者(41例女性,57例男性),平均年龄51岁(范围16 - 82岁),接受了128组单光子发射计算机断层扫描研究。进行铊-201和锝-99m HMPAO单光子发射计算机断层扫描研究以进行肿瘤定位和评估放射对大脑皮质的影响。同时进行了30次神经心理学测试和96次解剖成像(计算机断层扫描/磁共振成像)。平均放射剂量为52 Gy,分1.8至2 Gy/分次给予。32例患者同时平均接受了160 mCi的碘-125表皮生长因子受体(I-125 EGFr)治疗。平均随访期为34个月。在HMPAO研究、神经心理学测试或解剖成像中,远离肿瘤部位的异常被解释为阳性;否则,被分类为阴性。
放射治疗前和放射治疗后HMPAO研究结果异常的分别有10/45(22%)和75/83(90%)。与神经心理学测试相比,放射治疗前和放射治疗后患者中,除肿瘤部位外,HMPAO研究显示一致性异常的分别有3/13(23%)和14/17(82%)。放射治疗前,22/30(76%)的患者中HMPAO与解剖成像的一致性更好,而在放射治疗后这一比例为24/67(36%)。放射治疗后HMPAO成像显示灌注异常明显更多。上述所有参数之间存在显著差异。结论:锝-99m HMPAO成像有助于评估放射治疗对大脑的影响,且与神经心理学测试高度一致。在识别放射诱导的变化方面,它优于解剖学研究。